LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

MASSACHUSETTS FINANCIAL SERVICES CO /MA/'s Holding History (CIK: 0000912938)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 577,319 Value ($000) $837 Avg Close — Range —
Q1 2024
Shares 1,540,840 Value ($000) $3,436 Avg Close — Range —
Q4 2023
Shares 1,354,678 Value ($000) $2,628 Avg Close — Range —
Q3 2023
Shares 1,363,190 Value ($000) $2,004 Avg Close — Range —
Q2 2023
Shares 1,373,218 Value ($000) $4,367 Avg Close — Range —
Q1 2023
Shares 1,391,408 Value ($000) $3,284 Avg Close — Range —
Q4 2022
Shares 1,288,527 Value ($000) $4,471 Avg Close — Range —
Q3 2022
Shares 1,059,897 Value ($000) $7,769 Avg Close — Range —
Q2 2022
Shares 988,109 Value ($000) $6,442 Avg Close — Range —
Q1 2022
Shares 995,531 Value ($000) $5,027 Avg Close — Range —
Q4 2021
Shares 968,065 Value ($000) $7,493 Avg Close — Range —
Q3 2021
Shares 975,190 Value ($000) $14,433 Avg Close — Range —
Q2 2021
Shares 987,928 Value ($000) $16,044 Avg Close — Range —